Pre-Exposure Prophylaxis (PrEP)
2
Pipeline Programs
5
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 program1
Cabotegravir Injection [Apretude]Phase 41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Human BioSciencesCabotegravir Injection [Apretude]
Kite PharmaPrEP-RN
Clinical Trials (2)
Total enrollment: 940 patients across 2 trials
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana
Start: Nov 2023Est. completion: Nov 2027500 patients
Phase 4Active Not Recruiting
Impact of Nursing Involvement on Implementation of HIV Prevention Services
Start: Apr 2021Est. completion: Mar 2022440 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.